Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
EEG/closed-circuit television long-term monitoring was used as a definitive diagnostic tool to identify and characterize 25 patients with pseudoepileptic
seizures
and a similar group of subjects with epilepsy, confirming the value of the procedure. The groups did not differ with respect to intelligence, neuropsychological impairment, or incidence of potential etiological factors for
seizures
. Scores on the Minnesota Multiphasic Personality Inventory (MMPI) and the Hypochondriasis, Hysteria, and
Schizophrenia
Scales were significantly higher for the pseudoepileptic group than for the other subjects. As a whole, the former patients exhibited an MMPI profile pattern frequently seen in the conversion form of hysteria. A set of three rules derived from the MMPI profiles was used to classify the patients correctly in 80-90% of cases. As evaluated by the Washington Psychosocial
Seizure
Inventory, psychosocial problems of patients with pseudoepileptic
seizures
were more severe in certain areas, and appeared to reflect early family background problems and inappropriate management of their disorders.
...
PMID:Intensive EEG monitoring and psychological studies of patients with pseudoepileptic seizures. 669 85
Data pointing to possible combination of
schizophrenia
with epilepsy and the convulsive syndrome are analyzed. It has been found that
schizophrenia
starts very infrequently from a convulsive
seizure
, and still less frequently turns into epilepsy. Such a conversion was observed by the authors only in 4 out of 15,460
schizophrenia
cases: this figure is much lower than the incidence of both
schizophrenia
and epilepsy among healthy population.
...
PMID:[Possible correlation between schizophrenia and epilepsy]. 702 96
Ten epileptic patients developed interictal psychosis while being treated in hospital for
seizure
control. They were subjected to intensive behavioral, video-electroencephalographic, and serum anticonvulsant monitoring for an average of 7.1 weeks in a specialized epilepsy unit. In 9 patients, the interictal psychosis was indistinguishable from acute
schizophrenia
. Only 5 of these patients had complex partial seizures; the other 4 showed evidence of generalized epilepsies. Thus a "unique" association between schizophreniform psychosis and complex partial seizures, noted by previous authors, could not be confirmed. Only 1 patient showed normalization of the electroencephalogram during psychosis and an inverse relationship between psychosis and
seizure
frequency. In most cases the emergence of psychosis could not be explained. Interictal psychosis in epilepsy appears to be a spectrum of disorders that may be multifactorially determined.
...
PMID:Intensive monitoring of interictal psychosis in epilepsy. 711 11
Clozapine is a novel antipsychotic agent effective in treating refractory
schizophrenia
. Clozapine produces fewer extrapyramidal effects than other neuroleptics, although agranulocytosis and
seizures
are significant adverse effects. To characterize the spectrum of clozapine-related electroencephalographic abnormalities, we identified 10 patients who had electroencephalograms (EEGs) performed before and during clozapine treatment. These 10 patients represented a subset of individuals participating in an investigational trial. During clozapine treatment, five developed myoclonus and one experienced a generalized tonic-clonic seizure. Records were retrospectively reviewed by an electroencephalographer blinded to the patient's history and medications. All patients had normal EEGs before clozapine treatment. While receiving clozapine (250-900 mg daily), all patients developed background slowing in the theta and often delta ranges. Additionally, 7 patients exhibited bilateral spike, polyspike and slow wave discharges, one with a photoparoxysmal response. Follow-up EEGs performed in 4 of these 7 patients after a decrease in clozapine dosage and/or addition in valproic acid showed diminished epileptiform activity.
...
PMID:Spectrum of EEG abnormalities during clozapine treatment. 752 49
We examined the medical records of electroconvulsive therapy (ECT) recipients who concurrently received clozapine (n = 7). The patients tolerated ECT, with standard electrical stimulus parameters, without complications. No patients had tardive
seizures
. The
seizure
duration during ECT increased, as recorded by electroencephalogram and cuff technique, nonsignificantly by a mean of +2.4 s (range of duration: 17-54 s) while on clozapine. Patient response as evaluated with Brief Psychiatric Rating Scale scores showed a total improvement of 26.9%, improvement in positive signs of
schizophrenia
of 25.3%, and improvement in negative signs of 21.3%. Hallucinatory behavior (41.7%) and disorganization (45.5%) were markedly reduced. Combined clozapine and ECT appears as safe as other neuroleptics with ECT, with comparable clinical improvements.
...
PMID:Seizure activity in combined clozapine and ECT: a retrospective view. 755 49
Gray matter heterotopias (GMHs) are a type of neuronal migration anomaly in which collections of normal neurons are abnormally located secondary to an arrest of radial migration. They are often manifested clinically by
seizures
and cognitive, motor, and language deficits. Through magnetic resonance imaging, we have observed two cases in patients presenting with symptoms of
schizophrenia
, but no neurological abnormalities, and otherwise normal scans. While the incidence of GMH among normal individuals is unknown, it is possible that this particular anomaly may occur in schizophrenic patients at a higher rate than in the normal population. Furthermore, neuronal migration abnormalities may be involved in the pathogenesis of the disorder among a small subset of patients with
schizophrenia
.
...
PMID:Gray matter heterotopias in schizophrenia. 756 65
The authors report an 85-year-old man with
schizophrenia
, who had undergone bilateral frontal gyrectomy at the age of 44 and had a single series of convulsions 6 months after the psychosurgery. Forty-one years later, he had developed partial
seizures
with secondary generalized
seizures
, and died of partial status epilepticus. Ictal EEG showed generalized high-amplitude spikes or sharp waves spreading from the left frontal region. Interictal EEG showed slowing of background activity and high-amplitude paroxysmal discharges on the left frontal and central regions. Postmortem examination of the brain revealed tissue defects in the superior and middle frontal gyri caused by resection at the time of gyrectory and old cysts in the deep frontal white matter as late sequelae of the psychosurgery. There was fibrillary gliosis in the surrounding cerebral convolutions and the deep white matter. We considered that the glial scar in the frontal lobes, on the left side in particular, had developed the epileptogenic focus. The pathophysiological mechanism by which the intractable epileptic
seizures
appeared 41 years after psychosurgery is discussed.
...
PMID:[Partial status epilepticus developed 41 years after psychosurgery--an electroencephalographic and neuropathological study]. 760 86
Electroconvulsive therapy is used in the treatment of affective disorders and
schizophrenia
and experimental electroconvulsive shock may serve as an animal model for this treatment. The aim of this study was to investigate a possible role for neurotrophins in the mechanism of action of experimental electroconvulsive shock and thus in clinical electroconvulsive therapy. The effect of electroconvulsive shock on levels of messenger RNAs encoding the neurotrophin brain-derived neurotrophic factor and the receptor trkB in rat hippocampus was determined by in situ hybridization with RNA probes 1, 3, 9 and 27 h following the shock. Brain-derived neurotrophic factor messenger RNA levels were increased at 1, 3 and 9 h following the shock and normalized after 27 h. Granule cells of the dentate gyrus showed a more rapid response as compared to hilar cells and pyramidal cells of CA1. Total trkB messenger RNA levels, including the transcripts for both the truncated and full length trkB receptor protein (gp95trkB and gp145trkB, respectively), showed a pattern of increase very similar to that of the brain-derived neurotrophic factor messenger RNA. However, using a probe selective for the full length (gp145trkB) trkB messenger RNA, we determined a delayed pattern of activation with significant increase only at 3 and 9 h after the shock. In hippocampus total trkB messenger RNA was found to consist of approximately one-quarter of mRNA encoding gp145trkB and three-quarters encoding gp95trkB as revealed by RNAase protection. While brain-derived neurotrophic factor and the truncated trkB messenger RNAs appear to increase with a similar pattern, suggesting a similar mechanism of activation by electroconvulsive shock, full length receptor trkB messenger RNA appears to increase with a delayed pattern suggesting a separate mechanism of activation. Electroconvulsive shock-induced
seizures
seem to include activation of a brain neurotrophin known to be important for neuronal plasticity.
...
PMID:Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. 760 68
We report on a 57 year-old patient with
schizophrenia
. After a 30 years course of the disease, he developed previous unknown psychopathological symptoms, and therapeutic interventions (neuroleptic drugs and electroconvulsive therapy) failed. Neurological examination and EEG revealed the diagnosis of complex partial epileptic
seizures
. MRI showed bitemporal localized cerebral lesions. Discussion focusses on generalization of microseizures in deep brain structures, and "kindling effect" of electroconvulsive therapy in a patient with pre-existing cerebral lesions.
...
PMID:[Schizophrenia and partial complex seizures--case report in diagnosis and differential diagnosis of psychoses and epilepsy]. 781 Jan 55
MB suffered an episode of status epilepticus of febrile origin at the age of 20 months. This was followed at two years by complex partial seizures of temporal lobe origin and at eight years he had learning difficulties arising from the dominant hemisphere. Subsequent symptoms included auditory, visual and olfactory hallucinations which were not controlled by antipsychotics or antiepileptics. EEG and MRI were unhelpful and alternating diagnoses of
schizophrenia
and temporal lobe epilepsy were made. Now aged 17 years, he has a diagnosis of schizophreniform psychosis with temporal lobe abnormality from status epilepticus in childhood, and is managed by an adult psychiatrist. His symptoms persist.
Seizure
1994 Dec
PMID:Psychosis or epilepsy--a diagnostic and management quandary. 789 50
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>